Ads
related to: moderna
Search results
Moderna, Inc. (NASDAQ:MRNA) Director Sells $30,088,098.88 in Stock
ETF DAILY NEWS· 7 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 202,832 shares of the stock in a transaction that occurred on Tuesday, June 11th. The shares were ...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via Yahoo News· 18 hours agoThe state of Kansas filed a lawsuit on Monday against pharmaceutical company Pfizer, alleging the...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Morningstar· 5 days agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine ...
Moderna, Inc. (NASDAQ:MRNA) Insider Sells $766,810.02 in Stock
ETF DAILY NEWS· 6 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 5,178 shares of the company’s stock in a transaction dated Monday, June 10th. Following the ...
Moderna says next-gen COVID shot effective in study
BioPharma Dive via Yahoo Finance· 5 days agoTrial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases...
Oppenheimer Increases Moderna (NASDAQ:MRNA) Price Target to $179.00
ETF DAILY NEWS· 5 days agoModerna (NASDAQ:MRNA – Get Free Report) had its target price hoisted by analysts at Oppenheimer from $163.00 to $179.00 in a research report issued to clients and investors ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Bmo Transfers Three Ark Etfs From The Tsx To Cboe Canada | Investing.com Canada
Investing.com· 5 hours agoMarket Analysis by Canadian ETF Market covering: . Read Canadian ETF Market's Market Analysis on...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 5 hours agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...